Twist Bioscience Corp
NASDAQ:TWST

Watchlist Manager
Twist Bioscience Corp Logo
Twist Bioscience Corp
NASDAQ:TWST
Watchlist
Price: 32.22 USD -0.25% Market Closed
Market Cap: 2B USD

Wall Street
Price Targets

TWST Price Targets Summary
Twist Bioscience Corp

Wall Street analysts forecast TWST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TWST is 39.29 USD with a low forecast of 32.32 USD and a high forecast of 60.03 USD.

Lowest
Price Target
32.32 USD
0% Upside
Average
Price Target
39.29 USD
22% Upside
Highest
Price Target
60.03 USD
86% Upside
Twist Bioscience Corp Competitors:
Price Targets
PBYI
Puma Biotechnology Inc
12% Downside
CRNX
Crinetics Pharmaceuticals Inc
72% Upside
ASMB
Assembly Biosciences Inc
10% Upside
2480
Beijing Luzhu Biotechnology Co Ltd
36% Upside
TVTX
Travere Therapeutics Inc
23% Upside
MDGL
Madrigal Pharmaceuticals Inc
1% Upside
SCLP
Scancell Holdings PLC
208% Upside
VITR
Vitrolife AB
39% Upside

Revenue
Forecast

Revenue Estimate
Twist Bioscience Corp

For the last 8 years the compound annual growth rate for Twist Bioscience Corp's revenue is 56%. The projected CAGR for the next 3 years is 16%.

56%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Twist Bioscience Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TWST's stock price target?
Price Target
39.29 USD

According to Wall Street analysts, the average 1-year price target for TWST is 39.29 USD with a low forecast of 32.32 USD and a high forecast of 60.03 USD.

What is Twist Bioscience Corp's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Twist Bioscience Corp's revenue is 56%. The projected CAGR for the next 3 years is 16%.

Back to Top